Nuwellis (Nuwellis) Debt-to-Asset : 0.08 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Nuwellis Debt-to-Asset?

Nuwellis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.22 Mil. Nuwellis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.54 Mil. Nuwellis's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $9.77 Mil. Nuwellis's debt to asset for the quarter that ended in Dec. 2023 was 0.08.

Nuwellis Debt-to-Asset Historical Data

The historical data trend for Nuwellis's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuwellis Debt-to-Asset Chart

Nuwellis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.08

0.02

0.04

0.08

Nuwellis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.04	0.05	0.06	0.07	0.08

Competitive Comparison of Nuwellis's Debt-to-Asset

For the Medical Devices subindustry, Nuwellis's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuwellis's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nuwellis's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Nuwellis's Debt-to-Asset falls into.

Nuwellis Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Nuwellis's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.216	+	0.544)	/	9.77
	=	0.08

Nuwellis's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.216	+	0.544)	/	9.77
	=	0.08

Nuwellis (NAS:NUWE) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Nuwellis Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Nuwellis's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuwellis (Nuwellis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nuwellis Inc (NAS:NUWE) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

22SA:Germany 22SA:Germany

Address

12988 Valley View Road, Eden Prairie, MN, USA, 55344

Website

https://www.nuwellis.com

Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.

Executives

David Mcdonald	director	6 KEMPTON PLACE, #12, SARATOGA SPRINGS NY 12866
Archelle Georgiou Feldshon	director	1420 SHORELINE DRIVE, WAYZATA MN 55391
Robert Benjamin Scott	officer: Chief Financial Officer	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Kendrick Mccormick	director	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Gregory D Waller	director	1717 W COLLINS AVENUE, ORANGE CA 92867
Jon W Salveson	director	800 NICOLLET MALL, MINNEAPOLIS MN 55402
Nestor Jr. Jaramillo	officer: Chief Commercial Officer	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Lynn Larson Blake	officer: Chief Financial Officer	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
George Montague	officer: CFO and Treasurer	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Neil P Ayotte	officer: SVP, Secretary, GC & CCO	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Paul Wotta	officer: Principal Accounting Officer	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Claudia Drayton	officer: Chief Financial Officer	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Thomas P. Lynch	officer: Chief Legal/Compliance Officer	3344 N. TORREY PINES COURT, LA JOLLA CA 92037
Steven Frank Brandt	director	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Maria Rosa Costanzo	director	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344